Golden House Ltd (TLV:GOHO)
1,034.00
+2.00 (0.19%)
Jun 12, 2026, 1:44 PM IDT
Golden House Revenue
Golden House had revenue of 13.31M ILS in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 46.05M, up 11.98% year-over-year. In the year 2024, Golden House had annual revenue of 39.82M, down -26.66%.
Revenue (ttm)
46.05M
Revenue Growth
+11.98%
P/S Ratio
3.48
Revenue / Employee
396.95K
Employees
116
Market Cap
160.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.82M | -14.48M | -26.66% |
| Dec 31, 2023 | 54.30M | -1.68M | -3.00% |
| Dec 31, 2022 | 55.97M | -237.00K | -0.42% |
| Dec 31, 2021 | 56.21M | -3.80M | -6.33% |
| Dec 31, 2020 | 60.01M | 3.40M | 6.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 54.78B |
| Danel (Adir Yeoshua) | 2.93B |
| Amal Holdings A.D. | 2.18B |
| Rekah Pharmaceutical Industry | 304.15M |
| InterCure | 270.20M |
| BrainsWay | 177.50M |
| Seach Medical Group | 157.16M |
| Epitomee Medical | 679.04K |